Cantel Medical Corp., a provider of instrument reprocessing and infection prevention products and services, today announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg. Co., a 111-year-old global manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. This combination creates a provider of comprehensive infection prevention, instrument and instrument management solutions to optimize dental practitioners’ need for superior clinical performance and best-in-class infection prevention practices.
Cantel is acquiring Hu-Friedy for $725 million in upfront cash and stock consideration, and up to $50 million in earnout payments payable in cash and stock conditional on the achievement of commercial milestones in the first eighteen months after closing. The transaction structure is anticipated to result in tax benefits to Cantel presently valued at more than $100 million, which would result in a net purchase price of $625 million for the upfront consideration and up to approximately $675 million in consideration including potential earnout payments.
To view the full story, please click here.
Sign up for Oral Health Group’s weekly enewsletter to have news delivered straight to your inbox!
